Evaxion Biotech A/S
EVAX
$1.65
$0.063.77%
NASDAQ
12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 6.61% | 12.29% | -57.65% | -- | -- |
Total Receivables | 72.84% | -13.85% | -17.75% | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -43.56% | -42.47% | -32.16% | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 4.97% | -5.87% | -50.84% | -- | -- |
|
|||||
Total Current Assets | 4.97% | -5.87% | -50.84% | -- | -- |
Net Property, Plant & Equipment | -19.09% | -14.84% | -7.10% | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 5.10% | -21.89% | -46.30% | -- | -- |
Total Assets | -3.13% | -9.09% | -41.48% | -- | -- |
|
|||||
Total Accounts Payable | 10.38% | 51.81% | 28.97% | -- | -- |
Total Accrued Expenses | -3.80% | -- | 153.26% | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -2.47% | 1.49% | 10.48% | -- | -- |
Total Finance Division Other Current Liabilities | -97.78% | -58.52% | 240.79% | -- | -- |
Total Other Current Liabilities | -97.78% | -58.52% | 240.79% | -- | -- |
Total Current Liabilities | -38.34% | -5.65% | 88.30% | -- | -- |
|
|||||
Total Current Liabilities | -38.34% | -5.65% | 88.30% | -- | -- |
Long-Term Debt | -5.67% | 2.30% | 7.95% | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -14.56% | -10.07% | -2.87% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -5.37% | -1.36% | 3.47% | -- | -- |
Total Liabilities | -19.76% | -1.69% | 28.39% | -- | -- |
|
|||||
Common Stock & APIC | 14.04% | 15.17% | 10.32% | -- | -- |
Retained Earnings | -9.79% | -34.08% | -25.77% | -- | -- |
Treasury Stock & Other | 5.41% | 379.24% | 3.74% | -- | -- |
Total Common Equity | 65.07% | -50.57% | -156.96% | -- | -- |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 65.07% | -50.57% | -156.96% | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 65.07% | -50.57% | -156.96% | -- | -- |
|